Live Chat

Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Nov 20, 20:18

BioNTech (NASDAQ:BNTX) Trading Down 2.2% - Here's What Happened

BioNTech SE
Webhose 2024 Nov 20, 17:17

BioNTech (NASDAQ:BNTX) Trading Down 2.2% – Here’s What Happened

BioNTech SE
Webhose 2024 Nov 19, 23:15

Is BioNTech SE (BNTX) the Best German Stock to Buy Now?

BioNTech SE
Webhose 2024 Nov 19, 20:30

BioNTech (NASDAQ:BNTX) Trading 4.9% Higher - Still a Buy?

BioNTech SE
Webhose 2024 Nov 19, 12:38

Evercore ISI upgrades BioNTech, says 'chaos' of RFK Jr.'s nomination presents buying opportunity

BioNTech SE
Webhose 2024 Nov 19, 12:34

BioNTech (NASDAQ:BNTX) Raised to "Outperform" at Evercore ISI

BioNTech SE
Webhose 2024 Nov 19, 09:36

Berenberg sees upside in BioNTech stock—cancer pipeline momentum through 2025 By Investing.com

BioNTech SE
Webhose 2024 Nov 19, 09:35

Berenberg Bank Begins Coverage on BioNTech (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 19, 02:36

BioNTech stock upgraded as Evercore ISI highlights undervaluation and growth By Investing.com

BioNTech SE
Webhose 2024 Nov 19, 00:00

Other news to note for November 19, 2024 | BioWorld

BioNTech SE
Webhose 2024 Nov 18, 13:12

BioNTech's (BNTX) "Buy" Rating Reiterated at HC Wainwright

BioNTech SE
Webhose 2024 Nov 18, 07:38

Goldman Sachs Reaffirms Their Buy Rating on BioNTech SE (BNTX)

BioNTech SE
Webhose 2024 Nov 18, 07:31

FY2024 EPS Estimates for BioNTech Decreased by Analyst

BioNTech SE
Webhose 2024 Nov 17, 02:04

BioNTech SE (NASDAQ:BNTX) Short Interest Update

BioNTech SE
Webhose 2024 Nov 16, 16:16

Vaccine Stocks Fall After MAGA Announces Anti-Vaxx Health Secretary: RFK Jr.

BioNTech SE
Webhose 2024 Nov 15, 17:51

BioNTech (NASDAQ:BNTX) Shares Gap Down - Here's What Happened

BioNTech SE
Webhose 2024 Nov 15, 17:31

Pharma Stocks Take Nose Dive After Trump Announces RFK Jr. For HHS

BioNTech SE
Webhose 2024 Nov 14, 16:34

BioNTech (NASDAQ:BNTX) Given Buy Rating at Canaccord Genuity Group

BioNTech SE
Webhose 2024 Nov 14, 03:57

Germany’s BioNTech buys China’s Biotheus in US$800 million push into cancer drugs | South China Morning Post

BioNTech SE
Webhose 2024 Nov 14, 00:00

BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up - November 14, 2024 - Zacks.com

BioNTech SE
Webhose 2024 Nov 14, 00:00

Biontech acquiring PM-8002 through $950M Biotheus buyout | BioWorld

BioNTech SE
Webhose 2024 Nov 13, 19:58

BioNTech to Acquire Biotheus for $800 Million to Expand Oncology Portfolio

BioNTech SE
Webhose 2024 Nov 13, 13:10

BioNTech To Buy Biotheus In Upfront Payment Of $800 Mln

BioNTech SE
Webhose 2024 Nov 13, 11:58

BioNTech to Acquire Biotheus to Boost Oncology Strategy | The Manila Times

BioNTech SE
Webhose 2024 Nov 12, 13:06

Baillie Gifford & Co. Acquires 31,773 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 12, 11:15

TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV) | Markets Insider

BioNTech SE
Webhose 2024 Nov 11, 08:20

US Bancorp DE Trims Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 09, 18:16

BioNTech (NASDAQ:BNTX) Upgraded to Buy at The Goldman Sachs Group

BioNTech SE
Webhose 2024 Nov 08, 12:45

The Goldman Sachs Group Upgrades BioNTech (NASDAQ:BNTX) to Buy

BioNTech SE
Webhose 2024 Nov 08, 11:11

Goldman Sachs upgrades BioNTech to buy, sees stock surging more than 25%

BioNTech SE
Webhose 2024 Nov 07, 12:30

FY2024 EPS Estimates for BioNTech Cut by HC Wainwright

BioNTech SE
Webhose 2024 Nov 07, 11:04

BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.

BioNTech SE
Webhose 2024 Nov 07, 10:12

Van ECK Associates Corp Sells 25,216 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 07, 09:32

BioNTech SE (NASDAQ:BNTX) Receives $135.54 Consensus Target Price from Brokerages

BioNTech SE
Webhose 2024 Nov 07, 09:11

Robeco Institutional Asset Management B.V. Cuts Stake in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 07, 08:57

Van ECK Associates Corp Reduces Stock Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 05, 20:08

BioNTech stock target cut to $122 from $132 by TD Cowen By Investing.com

BioNTech SE
Webhose 2024 Nov 05, 19:41

TD Cowen Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech SE
Webhose 2024 Nov 05, 17:56

BioNTech (NASDAQ:BNTX) Announces Quarterly Earnings Results

BioNTech SE
Webhose 2024 Nov 05, 07:02

BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... By GuruFocus

BioNTech SE
Webhose 2024 Nov 04, 21:36

BMO raises BioNTech target to $126 on strong revenue By Investing.com

BioNTech SE
Webhose 2024 Nov 04, 17:16

Earnings call: BioNTech reports growth in oncology and vaccine sectors By Investing.com

BioNTech SE
Webhose 2024 Nov 04, 12:03

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update | The Manila Times

BioNTech SE
Webhose 2024 Nov 04, 11:07

BioNTech Q3 Net Profit Rises; Backs FY24 Revenue Outlook Range, But At The Low End

BioNTech SE
Webhose 2024 Nov 04, 07:24

BofA maintains Buy on BioNTech, price target at $150 By Investing.com

BioNTech SE
Webhose 2024 Nov 04, 00:00

Adapted coronavirus vaccines drive BioNTech sales

BioNTech SE
Webhose 2024 Nov 03, 14:21

Lodestone Wealth Management LLC Invests $8.37 Million in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 02, 07:15

BioNTech SE (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

BioNTech SE
Webhose 2024 Nov 01, 08:22

abrdn plc Acquires 173,969 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Nov 01, 07:14

Blue Trust Inc. Increases Stock Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Oct 31, 11:51

BioNTech to Host Innovation Series R&D Day on November 14, 2024 | The Manila Times

BioNTech SE
Webhose 2024 Oct 30, 08:00

International Assets Investment Management LLC Takes Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Oct 29, 12:51

China Universal Asset Management Co. Ltd. Buys 7,340 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Oct 28, 13:46

Metastatic Melanoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

BioNTech SE
Webhose 2024 Oct 28, 13:18

BioNTech SE (NASDAQ:BNTX) Sees Significant Increase in Short Interest

BioNTech SE
Webhose 2024 Oct 28, 12:07

BioNTech (BNTX) Set to Announce Earnings on Monday

BioNTech SE
Webhose 2024 Oct 28, 09:37

DekaBank Deutsche Girozentrale Has $56.89 Million Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Oct 28, 00:00

Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - October 28, 2024 - Zacks.com

BioNTech SE
Webhose 2024 Oct 25, 00:00

BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - October 25, 2024 - Zacks.com

BioNTech SE
Webhose 2024 Oct 22, 07:01

Osiris Therapeutics (OTCMKTS:OSIR) versus BioNTech (NASDAQ:BNTX) Financial Review

BioNTech SE

Latest news

Frances Wang 2024 Nov 20, 16:00

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Cryptocurrencies
Mixed market performance
Neil Wilson 2024 Nov 20, 16:00

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

USD Tech S&P 500
Frances Wang 2024 Nov 19, 16:00

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

NVDA Stocks
Frances Wang 2024 Nov 19, 16:00

Bitcoin price hits record high over $93,800 as Trump rally resumes

Cryptocurrencies
Rising gold prices
Neil Wilson 2024 Nov 19, 16:00

Gold Shines, Bitcoin Surges, and Nvidia Earnings in Focus

Gold Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

What is the cryptocurrency market doing: Musk's DOGE Role Boosts Dogecoin

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

Bitcoin price prediction: BTC May Reach $100K Before New Year

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

25% upside, Nvidia stock (NVDA) has rocketed to all-time highs

Stocks

Info

Spread

1.0525

Spread (%)

1.0364 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

25508335616

Shares Outstanding

239740000

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.05

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A, as well as strategic partnership the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen africa's mrna vac

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat